March 05, 2015 5:26 AM ET

Biotechnology

Company Overview of Q Therapeutics, Inc.

Company Overview

Q Therapeutics, Inc., through its subsidiary, is engaged in developing human cell-based therapies intended to treat degenerative diseases of the brain and spinal cord, the primary components of the central nervous system. It develops Q-Cells that are healthy human glial cells intended for the treatment of amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, traumatic spinal cord injury, stroke, Huntington’s disease, Parkinson’s disease, and Alzheimer’s disease. The company was formerly known as Q Holdings, Inc. and changed its name to Q Therapeutics, Inc. in December 2012. Q Therapeutics, Inc. is based in Salt Lake City, Utah.

615 Arapeen Drive

Suite 102

Salt Lake City, UT 84108

United States

5 Employees

Phone:

801-582-5400

Fax:

801-582-5401

Key Executives for Q Therapeutics, Inc.

Chief Executive Officer, President and Director
Age: 65
Chief Financial Officer, Principal Accounting Officer and Vice President of Corporate Development
Age: 56
Senior Director of Research & Development
Regulatory Consultant
Compensation as of Fiscal Year 2014.

Q Therapeutics, Inc. Key Developments

Q Therapeutics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 10:45 AM

Q Therapeutics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 10:45 AM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Q Therapeutics, Inc. Appoints Hunter Jackson as Independent Member

Q Therapeutics, Inc. announced the appointment of Hunter Jackson, Ph.D. as an independent member to the company's Board of Directors. In addition, Dr. Jackson has agreed to serve on the Board's newly formed Governance and Nominating Committee; he will be joined on the Committee by current independent directors, Peter Grebow, Ph.D. and Peter Barton Hutt, Esq. Dr. Jackson brings to Q Therapeutics more than 30 years' experience in the life science industry.

Q Therapeutics, Inc. Presents at Swedish-American Life Science Summit 2014, Aug-21-2014 02:00 PM

Q Therapeutics, Inc. Presents at Swedish-American Life Science Summit 2014, Aug-21-2014 02:00 PM. Venue: EY Headquarters, Stockholm, Sweden. Speakers: Mahendra S. Rao, Scientific Co-Founder and Chief Scientific Consultant, Steven J. Borst, Chief Financial Officer, Principal Accounting Officer and Vice President of Corporate Development.

Similar Private Companies By Industry

Company Name Region
Anthill Technologies, Inc. United States
nanoRETE, Inc. United States
Percivia LLC United States
enEvolv, Inc. United States
MGI Pharma Biologics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Q Therapeutics, Inc., please visit www.qthera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.